These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24470517)

  • 21. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are European standard deviation targets for haemoglobin A1c too strict?
    Kilpatrick ES; Kilpatrick WS; Dominiczak MH; Small M
    Diabet Med; 1998 Nov; 15(11):920-3. PubMed ID: 9827845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus.
    Ain Q; Latif A; Jaffar SR; Ijaz A
    J Pak Med Assoc; 2017 Sep; 67(9):1353-1356. PubMed ID: 28924273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study.
    Shohat N; Tarabichi M; Tan TL; Goswami K; Kheir M; Malkani AL; Shah RP; Schwarzkopf R; Parvizi J
    Bone Joint J; 2019 Jul; 101-B(7_Supple_C):3-9. PubMed ID: 31256656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.
    Detournay B; Simon D; Guillausseau PJ; Joly D; Verges B; Attali C; Clement O; Briand Y; Delaitre O
    Diabetes Metab; 2012 Apr; 38(2):102-12. PubMed ID: 22252014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
    J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A low-GI diet is associated with a short-term improvement of glycaemic control in Asian patients with type 2 diabetes.
    Yusof BN; Talib RA; Kamaruddin NA; Karim NA; Chinna K; Gilbertson H
    Diabetes Obes Metab; 2009 Apr; 11(4):387-96. PubMed ID: 19175374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
    Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
    Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control.
    Suh S; Joung JY; Jin SM; Kim MY; Bae JC; Park HD; Lee MS; Lee MK; Kim JH
    Diabetes Metab; 2014 Sep; 40(4):272-7. PubMed ID: 24630733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycaemic indices and haemoglobin A1c as predictors for non-healing ulcers.
    Moore KJ; Dunn EC; Marcus EN; Koru-Sengul T
    J Wound Care; 2018 Apr; 27(Sup4):S6-S11. PubMed ID: 29641344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
    De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus.
    Thomas D; Elliott EJ
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006296. PubMed ID: 19160276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.